Colin H Quinn Selected Research

UAB 30

1/2021	9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
6/2020	Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colin H Quinn Research Topics

Disease

13	Neoplasms (Cancer) 06/2022 - 01/2019
10	Neuroblastoma 06/2022 - 01/2019
4	Hepatoblastoma 06/2022 - 01/2021
3	Carcinogenesis 01/2022 - 01/2021
1	Medulloblastoma 10/2019
1	Brain Neoplasms (Brain Tumor) 10/2019

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 01/2021
3	proto-oncogene proteins pimIBA 01/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2021 - 06/2020
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2022 - 06/2021
2	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 06/2021
2	UAB 30IBA 01/2021 - 06/2020
1	6- (4- (3- (methylsulfonyl)benzylamino)- 5- (trifluoromethyl)pyrimidin- 2- ylamino)- 3,4- dihydroquinolin- 2(1H)- oneIBA 06/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	CrizotinibIBA 07/2021
1	Sunitinib (Sutent)FDA Link 07/2021
1	Strap proteinIBA 06/2021
1	Small Interfering RNA (siRNA)IBA 06/2021
1	CytokinesIBA 04/2021
1	Extracellular Matrix ProteinsIBA 04/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2021
1	AZD1208IBA 01/2021
1	GSK343IBA 01/2021
1	RetinoidsIBA 10/2019

Therapy/Procedure

9	Therapeutics 04/2022 - 01/2019
1	Injections 06/2022
1	Oncolytic Virotherapy 02/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 12/2019